Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment

Cell Cycle

Volumn 12, Issue 1, 2013, Pages 88-97

  Ma, Wei ^a,e   Ma, Jing ^a,f   Xu, Jie ^a   Qiao, Chong ^a,g   Branscum, Adam ^b   Cardenas, Andres ^b   Baron, Andre T ^c,d   Schwartz, Peter ^a   Maihle, Nita J ^a   Huang, Yingqun ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e NORTH MINZU UNIVERSITY   (China)

^f CENTRAL SOUTH UNIVERSITY   (China)

^g China Medial University   (China)

Author keywords

BMP4; Lin28 Oct4; Ovarian cancer; Posttranscriptional; Tumor microenvironment

Indexed keywords

BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN 4; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN LIN28; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT;

EID: 84872307550     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23028     Document Type: Article

References (40)

1. Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer 2012; 12:133-43; PMID:22237392.
2. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488:522-6; PMID:22854781; http://dx.doi.org/10.1038/nature11287.
3. Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 2012; 488:527-30; PMID:22854777; http://dx.doi.org/10.1038/nature11344.
4. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012; 337:730-5; PMID:22855427; http://dx.doi.org/10.1126/science.1224676.
5. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stemlike state. Proc Natl Acad Sci USA 2011; 108:7950-5; PMID:21498687; http://dx.doi.org/10.1073/pnas.1102454108.
6. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146:633-44; PMID:21854987; http://dx.doi.org/10. 1016/j.cell.2011.07.026.
7. McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 2011; 121:3206-19; PMID:21737876; http://dx.doi.org/10.1172/JCI45273.
8. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RD, Boulanger CA, Smith GH. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci USA 2008; 105:14891-6; PMID:18809919; http://dx.doi.org/10.1073/pnas.0803214105.
9. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145:926-40; PMID:21663795; http://dx.doi.org/ 10.1016/j.cell.2011.04.029.
10. Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, Vonderhaar BK. Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines. Breast Cancer Res 2009; 11:R82; PMID:19906290; http://dx.doi.org/10.1186/bcr2449.
11. Ehrlich M, Horbelt D, Marom B, Knaus P, Henis YI. Homomeric and heteromeric complexes among TGF-β and BMP receptors and their roles in signaling. Cell Signal 2011; 23:1424-32; PMID:21515362; http://dx.doi.org/10. 1016/j.cellsig.2011.04.004.
12. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147:35-51; PMID:19762341; http://dx.doi.org/10.1093/jb/mvp148.
13. Kawabata M, Imamura T, Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 1998; 9:49-61; PMID:9720756; http://dx.doi.org/10.1016/S1359-6101(97)00036-1.
14. Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a subpopulation of stem cell-like cells in ovarian cancer. Oncogene 2010; 29:2153-9; PMID:20101213; http://dx.doi.org/10.1038/onc.2009.500.
15. Huang Y. A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA. Wiley Interdiscip Rev RNA 2012.
16. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol 2012; 22:474-82; PMID:22784697; http://dx.doi.org/10. 1016/j.tcb.2012.06.001.
17. Pei D. Regulation of pluripotency and reprogramming by transcription factors. J Biol Chem 2009; 284:3365-9; PMID:18819918; http://dx.doi.org/10.1074/ jbc.R800063200.
18. Qiu C, Ma Y, Wang J, Peng S, Huang Y. Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res 2010; 38:1240-8; PMID:19966271; http://dx.doi.org/10.1093/nar/gkp1071.
19. Peng S, Chen LL, Lei XX, Yang L, Lin H, Carmichael GG, et al. Genome-wide studies reveal that Lin28 enhances the translation of genes important for growth and survival of human embryonic stem cells. Stem Cells 2011; 29:496-504; PMID:21425412; http://dx.doi.org/10.1002/stem.591.
20. Lei XX, Xu J, Ma W, Qiao C, Newman MA, Hammond SM, et al. Determinants of mRNA recognition and translation regulation by Lin28. Nucleic Acids Res 2011; PMID:22210884.
21. Jin J, Jing W, Lei XX, Feng C, Peng S, Boris-Lawrie K, et al. Evidence that Lin28 stimulates translation by recruiting RNA helicase A to polysomes. Nucleic Acids Res 2011; 39:3724-34; PMID:21247876; http://dx.doi.org/10.1093/ nar/gkq1350.
22. Shepherd TG, Thériault BL, Nachtigal MW. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 2008; 414:95-105; PMID:18372118; http://dx.doi.org/10.1016/j.gene.2008.02.015.
23. Thériault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW. BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 2007; 28:1153-62; PMID:17272306; http://dx.doi.org/10.1093/ carcin/bgm015.
24. Thériault BL, Shepherd TG. On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research. J Ovarian Res 2011; 4:10; PMID:21699706; http://dx.doi.org/10.1186/1757-2215-4-10.
25. Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, et al. BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 2009; 2:4; PMID:19366455; http://dx.doi.org/10.1186/ 1757-2215-2-4.
26. Moll F, Millet C, Noël D, Orsetti B, Bardin A, Katsaros D, et al. Chordin is underexpressed in ovarian tumors and reduces tumor cell motility. FASEB J 2006; 20:240-50; PMID:16449796; http://dx.doi.org/10.1096/fj.05-4126com.
27. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002; 8:1323-7; PMID:12389040; http://dx.doi.org/10.1038/nm791.
28. Moeder CB, Giltnane JM, Moulis SP, Rimm DL. Quantitative, fluorescence-based in-situ assessment of protein expression. Methods Mol Biol 2009; 520:163-75; PMID:19381954; http://dx.doi.org/10.1007/978-1-60327-811-9-12.
29. Lucio-Eterovic AK, Singh MM, Gardner JE, Veerappan CS, Rice JC, Carpenter PB. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function. Proc Natl Acad Sci USA 2010; 107:16952-7; PMID:20837538; http://dx.doi.org/10.1073/pnas.1002653107.
30. Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 2011; 26:77-83; PMID:21355779; http://dx.doi.org/10.1089/cbr.2010.0857.
31. Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011; 140:297-309; PMID:20951698; http://dx.doi.org/10.1053/j. gastro.2010.10.005.
32. Fessing MY, Atoyan R, Shander B, Mardaryev AN, Botchkarev VV Jr., Poterlowicz K, et al. BMP signaling induces cell-type-specific changes in gene expression programs of human keratinocytes and fibroblasts. J Invest Dermatol 2010; 130:398-404; PMID:19710687; http://dx.doi.org/10.1038/jid.2009.259.
33. Darr H, Benvenisty N. Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells 2009; 27:352-62; PMID:19038789; http://dx.doi.org/10.1634/stemcells.2008-0720.
34. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 2002; 20:1261-4; PMID:12426580; http://dx.doi.org/10.1038/nbt761.
35. Zhang P, Li J, Tan Z, Wang C, Liu T, Chen L, et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 2008; 111:1933-41; PMID:18042803; http://dx.doi.org/10.1182/blood-2007-02- 074120.
36. Lu L, Katsaros D, Shaverdashvili K, Qian B, Wu Y, de la Longrais IA, et al. Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer 2009; 45:2212-8; PMID:19477633; http://dx.doi.org/10.1016/ j.ejca.2009.05.003.
37. Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP, et al. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 2011; 147:1066-79; PMID:22118463; http://dx.doi.org/10.1016/j. cell.2011.10.039.
38. Camp RL, Dolled-Filhart M, King BL, Rimm DL. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res 2003; 63:1445-8; PMID:12670887.
39. nd edition, Chapman & Hall / CRC, Boca Rotan, Florida 2003.
40. Cox DR. Regression models and life-tables. J R Stat Soc [Ser A] 1972; 34:187-220.